• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IL4 通过抑制 DUSP4 来启动乳腺癌进展的动力学。

IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition.

机构信息

Department of Surgical, Oncological and Stomatological Sciences, University of Palermo, Palermo, Italy.

Regina Elena National Cancer Institute, Rome, Italy.

出版信息

Cancer Res. 2017 Jun 15;77(12):3268-3279. doi: 10.1158/0008-5472.CAN-16-3126. Epub 2017 Apr 11.

DOI:10.1158/0008-5472.CAN-16-3126
PMID:28400477
Abstract

The tumor microenvironment supplies proinflammatory cytokines favoring a permissive milieu for cancer cell growth and invasive behavior. Here we show how breast cancer progression is facilitated by IL4 secreted by adipose tissue and estrogen receptor-positive and triple-negative breast cancer cell types. Blocking autocrine and paracrine IL4 signaling with the IL4Rα antagonist IL4DM compromised breast cancer cell proliferation, invasion, and tumor growth by downregulating MAPK pathway activity. IL4DM reduced numbers of CD44/CD24 cancer stem-like cells and elevated expression of the dual specificity phosphatase DUSP4 by inhibiting NF-κB. Enforced expression of DUSP4 drove conversion of metastatic cells to nonmetastatic cells. Mechanistically, RNAi-mediated attenuation of DUSP4 activated the ERK and p38 MAPK pathways, increased stem-like properties, and spawned metastatic capacity. Targeting IL4 signaling sensitized breast cancer cells to anticancer therapy and strengthened immune responses by enhancing the number of IFNγ-positive CTLs. Our results showed the role of IL4 in promoting breast cancer aggressiveness and how its targeting may improve the efficacy of current therapies. .

摘要

肿瘤微环境提供促炎细胞因子,有利于癌症细胞生长和侵袭行为的许可环境。在这里,我们展示了脂肪组织和雌激素受体阳性及三阴性乳腺癌细胞类型分泌的 IL4 如何促进乳腺癌的进展。用 IL4Rα 拮抗剂 IL4DM 阻断自分泌和旁分泌 IL4 信号会通过下调 MAPK 通路活性来损害乳腺癌细胞的增殖、侵袭和肿瘤生长。IL4DM 通过抑制 NF-κB 减少 CD44/CD24 癌症干细胞样细胞的数量,并上调双特异性磷酸酶 DUSP4 的表达。通过强制表达 DUSP4,将转移性细胞转化为非转移性细胞。从机制上讲,通过 RNAi 介导的 DUSP4 衰减激活了 ERK 和 p38 MAPK 通路,增加了干细胞样特性,并产生了转移性能力。靶向 IL4 信号会通过增加 IFNγ 阳性 CTL 的数量来增强对乳腺癌细胞的抗癌治疗和免疫反应。我们的研究结果表明了 IL4 在促进乳腺癌侵袭性方面的作用,以及靶向它可能如何提高现有治疗方法的疗效。

相似文献

1
IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition.IL4 通过抑制 DUSP4 来启动乳腺癌进展的动力学。
Cancer Res. 2017 Jun 15;77(12):3268-3279. doi: 10.1158/0008-5472.CAN-16-3126. Epub 2017 Apr 11.
2
Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.由于 DUSP4 的缺失导致 MAPK 通路的激活促进了基底样乳腺癌中癌症干细胞样表型的出现。
Cancer Res. 2013 Oct 15;73(20):6346-58. doi: 10.1158/0008-5472.CAN-13-1385. Epub 2013 Aug 21.
3
Metalloprotease-dependent activation of EGFR modulates CD44/CD24 populations in triple negative breast cancer cells through the MEK/ERK pathway.金属蛋白酶依赖性 EGFR 激活通过 MEK/ERK 通路调节三阴性乳腺癌细胞中的 CD44/CD24 群体。
Breast Cancer Res Treat. 2017 Nov;166(2):421-433. doi: 10.1007/s10549-017-4440-0. Epub 2017 Aug 8.
4
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.雌激素受体阴性乳腺癌中磷酸酶的分析确定双特异性磷酸酶4是生长和侵袭的关键调节因子。
Breast Cancer Res Treat. 2016 Aug;158(3):441-54. doi: 10.1007/s10549-016-3892-y. Epub 2016 Jul 8.
5
Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency.他汀类药物通过恢复 DUSP4 缺陷来影响 ETS1 过表达的三阴性乳腺癌细胞。
Sci Rep. 2016 Sep 8;6:33035. doi: 10.1038/srep33035.
6
Genomic Loss of DUSP4 Contributes to the Progression of Intraepithelial Neoplasm of Pancreas to Invasive Carcinoma.基因组缺失 DUSP4 促进胰腺上皮内瘤变向浸润性癌的进展。
Cancer Res. 2016 May 1;76(9):2612-25. doi: 10.1158/0008-5472.CAN-15-1846. Epub 2016 Mar 3.
7
Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.MAP 激酶磷酸酶 DUSP4 的表达与结直肠癌(CRC)中的微卫星不稳定性相关,并导致细胞增殖增加。
Int J Cancer. 2013 Apr 1;132(7):1537-46. doi: 10.1002/ijc.27834. Epub 2012 Nov 23.
8
Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.敲低双特异性磷酸酶 4 增强 MCF-7 和 MCF-7/ADR 乳腺癌细胞对阿霉素的化疗敏感性。
Exp Cell Res. 2013 Dec 10;319(20):3140-9. doi: 10.1016/j.yexcr.2013.08.023. Epub 2013 Sep 3.
9
Patterns of Dual-Specific Phosphatase 4 mRNA Expression Before and after Neoadjuvant Chemotherapy in Breast Cancer.乳腺癌新辅助化疗前后双特异性磷酸酶4 mRNA表达模式
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1051-1055. doi: 10.31557/APJCP.2019.20.4.1051.
10
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.新辅助化疗后残留乳腺癌的分析鉴定出 DUSP4 缺陷是耐药的一种机制。
Nat Med. 2012 Jul;18(7):1052-9. doi: 10.1038/nm.2795.

引用本文的文献

1
Dual-Specificity Protein Phosphatases Targeting Extracellular Signal-Regulated Kinases: Friends or Foes in the Biology of Cancer?靶向细胞外信号调节激酶的双特异性蛋白磷酸酶:癌症生物学中的朋友还是敌人?
Int J Mol Sci. 2025 Aug 28;26(17):8342. doi: 10.3390/ijms26178342.
2
Crosstalk between noncoding RNAs and autophagy in renal cell carcinoma: Deciphering molecular pathways and therapeutic prospects.肾细胞癌中非编码RNA与自噬之间的相互作用:解读分子途径及治疗前景
Cancer Cell Int. 2025 Sep 2;25(1):318. doi: 10.1186/s12935-025-03957-x.
3
GATA3-Driven ceRNA Network in Lung Adenocarcinoma Bone Metastasis Progression and Therapeutic Implications.
GATA3驱动的ceRNA网络在肺腺癌骨转移进展中的作用及治疗意义
Cancers (Basel). 2025 Feb 6;17(3):559. doi: 10.3390/cancers17030559.
4
A Novel Tumor on Chip Mimicking the Breast Cancer Microenvironment for Dynamic Drug Screening.一种新型的芯片肿瘤,模拟乳腺癌微环境用于动态药物筛选。
Int J Mol Sci. 2025 Jan 25;26(3):1028. doi: 10.3390/ijms26031028.
5
Infiltration of innate and adoptive lymphoid cells in 4T1 and MC4-L2 breast cancer models.4T1和MC4-L2乳腺癌模型中固有和过继性淋巴细胞的浸润
Iran J Basic Med Sci. 2025;28(1):63-71. doi: 10.22038/ijbms.2024.80535.17434.
6
HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer.HUNK 作为三阴性乳腺癌中肿瘤相关巨噬细胞的关键调节因子。
Oncoimmunology. 2024 Jun 5;13(1):2364382. doi: 10.1080/2162402X.2024.2364382. eCollection 2024.
7
CD44v5 domain regulates crosstalk between TNBC cells and tumor-associated macrophages by enhancing the IL-4R/STAT3 axis.CD44v5 结构域通过增强 IL-4R/STAT3 轴调节三阴性乳腺癌细胞与肿瘤相关巨噬细胞之间的串扰。
Cancer Sci. 2024 Jul;115(7):2235-2253. doi: 10.1111/cas.16200. Epub 2024 May 3.
8
Extract: Dietary Supplement for Reducing Mammary Tumor Incidence and Chemotherapy-Induced Toxicity.提取物:用于降低乳腺肿瘤发病率和化疗诱导毒性的膳食补充剂。
Foods. 2023 May 19;12(10):2053. doi: 10.3390/foods12102053.
9
CHMP4A stimulates CD8+ T-lymphocyte infiltration and inhibits breast tumor growth via the LSD1/IFNβ axis.CHMP4A 通过 LSD1/IFNβ 轴刺激 CD8+ T 淋巴细胞浸润并抑制乳腺肿瘤生长。
Cancer Sci. 2023 Aug;114(8):3162-3175. doi: 10.1111/cas.15844. Epub 2023 May 18.
10
Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation.从炎症角度理解肥胖重塑乳腺肿瘤免疫微环境的机制
Cancer Biol Med. 2023 Mar 8;20(4):268-86. doi: 10.20892/j.issn.2095-3941.2022.0547.